PAVMED INC Share Price Today: Live Updates & Key Insights

PAVMED INC share price today is $9.45, up 1.75%. The stock opened at $9.7 against the previous close of $9.69, with an intraday high of $9.7 and low of $9.5.

PAVMED INC Share Price Chart

PAVMED INC

us-stock
To Invest in {{usstockname}}
us-stock

PAVMED INC Share Price Performance

$9.45 0.0175(1.75%) PAVM at 23 Mar 2026 02:40 PM Medical Devices
Lowest Today 9.5
Highest Today 9.7
Today’s Open 9.7
Prev. Close 9.69
52 Week High 25.13
52 Week Low 6.00
Day’s Range: Low 9.5 High 9.7
52-Week Range: Low 6.00 High 25.13
1 day return -
1 Week return -4.51
1 month return +8.98
3 month return +3322.77
6 month return +2135.95
1 year return +1172.7
3 year return +105.1
5 year return -82.75
10 year return -

PAVMED INC Institutional Holdings

First Manhattan Co. LLC 1.67

Vanguard Group Inc 0.80

Vanguard Institutional Extnd Mkt Idx Tr 0.41

Geode Capital Management, LLC 0.39

Fidelity Extended Market Index 0.32

BlackRock Inc 0.17

Susquehanna International Group, LLP 0.16

NT Ext Equity Mkt Idx Fd - L 0.16

GSA Capital Partners LLP 0.15

CapTrust Financial Advisors 0.15

LPL Financial Corp 0.13

Northern Trust Corp 0.11

NT Ext Equity Mkt Idx Fd - NL 0.09

Virtu Financial LLC 0.09

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.07

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.06

State Street Corp 0.05

Fidelity Series Total Market Index 0.03

XTX Topco Ltd 0.03

Blackrock Extended Mkt Fund CF 0.03

XML Financial, LLC 0.02

Extended Equity Market Fund K 0.02

BAM - Small Cap 0.02

Fidelity Total Market Index 0.02

Northern Trust Extended Eq Market Idx 0.02

Spartan Total Market Index Pool G 0.02

Morgan Stanley - Brokerage Accounts 0.01

CWM, LLC duplicate 0.01

Tower Research Capital LLC 0.01

State St US Extended Mkt Indx NL Cl C 0.01

Wells Fargo & Co 0.00

SSgA U.S. Total Market Index Strategy 0.00

Extended Equity Market Fund M 0.00

Atlantic Trust Group, LLC 0.00

UBS Group AG 0.00

SIMPLEX TRADING, LLC 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

BNYM Mellon SL Market Completion UC1 0.00

BNYM Mellon NSL Mkt Completion Fund Inst 0.00

PAVMED INC Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

PAVMED INC Fundamentals

Market Cap 9.08 M

PB Ratio 1.0692

PE Ratio 0.0

Enterprise Value 42.54 M

Total Assets 30.66 M

Volume 14142

PAVMED INC Company Financials

Annual Revenue FY23:1515000 1.5M, FY22:377000 0.4M, FY21:500000 0.5M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:-4912000 -4.9M, FY22:-3237000 -3.2M, FY21:-85000 -0.1M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-70599000 -70.6M, FY22:-101294000 -101.3M, FY21:-50347000 -50.3M, FY20:-34329000 -34.3M, FY19:-15931309 -15.9M

Quarterly Revenue Q3/2025:5000 0.0M, Q2/2025:6000 0.0M, Q1/2025:8000 0.0M, Q3/2024:996000 1.0M, Q2/2024:979000 1.0M

Quarterly Profit Q3/2025:-50000 -0.1M, Q2/2025:-35000 -0.0M, Q1/2025:-71000 -0.1M, Q3/2024:-385000 -0.4M, Q2/2024:-992000 -1.0M

Quarterly Net worth Q3/2025:-5383000 -5.4M, Q2/2025:-11921000 -11.9M, Q1/2025:18968000 19.0M, Q3/2024:64399000 64.4M, Q2/2024:-10827000 -10.8M

About PAVMED INC & investment objective

Company Information PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York

Organisation Medical Devices

Employees 39

Industry Medical Devices

CEO Dr. Lishan Aklog M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

PAVMED INC FAQs

What is the share price of PAVMED INC today?

The current share price of PAVMED INC is $9.45.

Can I buy PAVMED INC shares in India?

Yes, Indian investors can buy PAVMED INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy PAVMED INC shares in India?

You can easily invest in PAVMED INC shares from India by:

Can I buy fractional shares of PAVMED INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of PAVMED INC?

PAVMED INC has a market cap of $9.08 M.

In which sector does PAVMED INC belong?

PAVMED INC operates in the Medical Devices sector.

What documents are required to invest in PAVMED INC stocks?

To invest, you typically need:

What is the PE and PB ratio of PAVMED INC?

The PE ratio of PAVMED INC is N/A and the PB ratio is 1.07.